Holen Sie sich die Stockscreener-App
1.18
2.61%
0.03
Schlusskurs vom Vortag:
$1.15
Offen:
$1.19
24-Stunden-Volumen:
43,203
Relative Volume:
0.13
Marktkapitalisierung:
$7.41M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-2.2264
EPS:
-0.53
Netto-Cashflow:
$-22.36M
1W Leistung:
+6.31%
1M Leistung:
-7.09%
6M Leistung:
-47.32%
1J Leistung:
-83.27%
1-Tages-Spanne:
$1.18
$1.22
1-Wochen-Bereich:
$1.08
$1.22
52-Wochen-Spanne:
$0.95
$8.996
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
1.18 | 7.41M | 5.64M | -23.88M | -22.36M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Industry News: Minnesota Co-Op Names Next CEO, ICL Acquires Lavie Bio - thedailyscoop.com
Why Evogene Ltd. (EVGN) Soared on Monday - MSN
10 Micro-, Small-Cap Companies Lead Monday’s Charge - Insider Monkey
ICL acquires Evogene subsidiary Lavie Bio By Investing.com - Investing.com South Africa
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI - Benzinga
Minerals Giant ICL to Acquire AI-Driven Ag Tech Company Lavie Bio - AgriBusiness Global
Evogene To Sell Majority Of Lavie Bio To ICL For Undisclosed Terms - Nasdaq
ICL acquires Evogene subsidiary Lavie Bio - Investing.com Australia
Evogene Announces Sale of Lavie Bio’s Assets to ICL - TipRanks
Strategic Acquisition: ICL Takes Over Evogene's Lavie Bio Including Advanced AI Platform for Agriculture - Stock Titan
Evogene (NASDAQ:EVGN) Share Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World
Evogene stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Evogene Schedules Third Quarter 2024 Financial Results Release - marketscreener.com
Evogene stock hits 52-week low at $0.99 amid market challenges - Investing.com Australia
Biomica CEO Set to Engage in Panel Discussion at 8th Annual Euro - GuruFocus
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene stock hits 52-week low at $1.18 amid market challenges - Investing.com Canada
Evogene stock hits 52-week low at $1.18 amid market challenges By Investing.com - Investing.com South Africa
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Decline in Short Interest - The AM Reporter
Evogene (NASDAQ:EVGN) Share Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split - Marketscreener.com
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Filing of Annual Report on Form 20-F - GuruFocus.com
AgPlenus Announces Discovery of a New Mode of Action for Fungici - GuruFocus.com
Evogene Ltd. Earnings Call: Growth Amid Challenges - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Evogene price target lowered to $6 from $11.25 at Alliance Global Partners - TipRanks
Evogene: Q4 Earnings Snapshot - Barchart
Evogene Ltd to Host Earnings Call - ACCESS Newswire
Evogene Ltd. (NASDAQ:EVGN) Short Interest Up 22.1% in February - Defense World
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - StreetInsider.com
Evogene Ltd. Reports Revenue Growth and Strategic Focus - TipRanks
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Evogene Q4 2024 beats EPS forecast, misses revenue - Investing.com
Evogene Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Evogene reports Q4 EPS 6c vs. ($1.30) last year - TipRanks
Evogene reports Q4 revenue miss, shares slip By Investing.com - Investing.com South Africa
Evogene reports Q4 revenue miss, shares slip - Investing.com
Evogene earnings beat by $0.66, revenue fell short of estimates - Investing.com India
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
2.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):